Oppenheimer Asset Management Inc. Buys 1,756 Shares of Bruker Co. (NASDAQ:BRKR)

Oppenheimer Asset Management Inc. boosted its stake in shares of Bruker Co. (NASDAQ:BRKRFree Report) by 8.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,859 shares of the medical research company’s stock after acquiring an additional 1,756 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Bruker were worth $1,362,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Congress Asset Management Co. MA bought a new stake in shares of Bruker during the second quarter worth $95,159,000. Norges Bank bought a new stake in shares of Bruker during the fourth quarter worth $76,958,000. Goldman Sachs Group Inc. grew its holdings in shares of Bruker by 84.2% during the second quarter. Goldman Sachs Group Inc. now owns 1,553,932 shares of the medical research company’s stock worth $114,867,000 after purchasing an additional 710,228 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Bruker by 4.5% during the first quarter. Vanguard Group Inc. now owns 11,253,314 shares of the medical research company’s stock worth $723,588,000 after purchasing an additional 487,688 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Bruker by 4,042.9% during the third quarter. Assenagon Asset Management S.A. now owns 320,166 shares of the medical research company’s stock worth $19,946,000 after purchasing an additional 312,438 shares during the last quarter. 79.78% of the stock is currently owned by institutional investors and hedge funds.

Bruker Stock Down 4.3 %

BRKR stock opened at $70.70 on Thursday. The company has a quick ratio of 1.04, a current ratio of 1.89 and a debt-to-equity ratio of 0.90. Bruker Co. has a twelve month low of $53.79 and a twelve month high of $84.84. The business has a 50 day moving average price of $71.41 and a two-hundred day moving average price of $66.07. The company has a market cap of $9.79 billion, a price-to-earnings ratio of 32.58, a P/E/G ratio of 2.34 and a beta of 1.14.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 15th. Stockholders of record on Friday, December 1st were paid a dividend of $0.05 per share. The ex-dividend date was Thursday, November 30th. This represents a $0.20 annualized dividend and a dividend yield of 0.28%. Bruker’s dividend payout ratio is currently 9.22%.

Analyst Ratings Changes

Several brokerages have recently commented on BRKR. Wells Fargo & Company assumed coverage on Bruker in a report on Tuesday, December 19th. They set an “equal weight” rating and a $72.00 target price on the stock. Wolfe Research assumed coverage on Bruker in a report on Wednesday, December 13th. They issued an “outperform” rating and a $80.00 price target on the stock. Finally, JPMorgan Chase & Co. decreased their price target on Bruker from $70.00 to $65.00 and set a “neutral” rating on the stock in a report on Tuesday, October 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $80.00.

Get Our Latest Stock Analysis on Bruker

Bruker Profile

(Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies.

Featured Stories

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKRFree Report).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.